Bioxodes is a clinical stage company developing a first-in-class drug candidate, Ir-CPI, for the prevention of thrombosis and neuroinflammation in haemorrhagic stroke patients.
About
Join us
Become a BioWin member today and benefit from improved networking and industry intelligence in the life sciences and health sector.